Allied-Bristol JV Picks Up Rights to Harvard's Work on Traditional Chinese Remedy

Wednesday, June 24, 2015

Source: FierceBiotechResearch

Just about a year after Bristol-Myers Squibb ($BMY) and Allied Minds got together to create Allied-Bristol Life Sciences (ABLS) with plans to collaborate on new biotech spinoffs, the joint venture has inlicensed research from Harvard University that may eventually lead to new drugs for fibrotic and autoimmune diseases.

View All News »